{
  "efficacy_receipt": {
    "provenance.flags": {
      "confidence_v2": false,
      "evidence_enabled": true,
      "evo_use_delta_only": true,
      "fusion_active": false
    },
    "top5_drugs": [
      {
        "citations_count": 0,
        "evidence_manifest.citations_count": 0,
        "evidence_manifest.pubmed_query": "TP53 p.R175H ovarian_cancer",
        "evidence_strength": 0.0,
        "evidence_tier": "consider",
        "name": "adavosertib"
      },
      {
        "citations_count": 0,
        "evidence_manifest.citations_count": 0,
        "evidence_manifest.pubmed_query": "TP53 p.R175H ovarian_cancer",
        "evidence_strength": 0.0,
        "evidence_tier": "insufficient",
        "name": "ceralasertib"
      },
      {
        "citations_count": 0,
        "evidence_manifest.citations_count": 0,
        "evidence_manifest.pubmed_query": "TP53 p.R175H ovarian_cancer",
        "evidence_strength": 0.0,
        "evidence_tier": "consider",
        "name": "paclitaxel"
      },
      {
        "citations_count": 0,
        "evidence_manifest.citations_count": 0,
        "evidence_manifest.pubmed_query": "TP53 p.R175H ovarian_cancer",
        "evidence_strength": 0.0,
        "evidence_tier": "insufficient",
        "name": "trametinib"
      },
      {
        "citations_count": 0,
        "evidence_manifest.citations_count": 0,
        "evidence_manifest.pubmed_query": "TP53 p.R175H ovarian_cancer",
        "evidence_strength": 0.0,
        "evidence_tier": "insufficient",
        "name": "bevacizumab"
      }
    ]
  },
  "literature_receipt": {
    "agent_error": "cannot import name 'genai' from 'google' (unknown location)",
    "agent_fallback": true,
    "pubmed_query": "TP53 p.R175H ovarian_cancer",
    "top_results_count": 0
  }
}

